Publicaciones en colaboración con investigadores/as de Institute Catalá Oncología (92)

2024

  1. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

  2. Toenail zinc and risk of prostate cancer in the MCC-Spain case-control study

    Environmental Research, Vol. 245

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

    Clinical Cancer Research, Vol. 29, Núm. 20, pp. 4166-4177

  3. Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2665-2678), 10.1007/s12094-023-03203-8)

    Clinical and Translational Oncology

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries

    Science of the Total Environment, Vol. 854

  6. Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study

    The Lancet Oncology, Vol. 24, Núm. 9, pp. 1029-1041

  7. SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)

    Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2665-2678

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  2. Sleep and breast and prostate cancer risk in the MCC-Spain study

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Consumption of ultra-processed food and drinks and chronic lymphocytic leukemia in the mcc-spain study

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 10

  2. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

  3. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study)

    International Journal of Cancer, Vol. 148, Núm. 6, pp. 1360-1371

  4. Greenhouse gases emissions from the diet and risk of death and chronic diseases in the EPIC-Spain cohort

    European journal of public health, Vol. 31, Núm. 1, pp. 130-135

  5. Inflammatory potential of the diet and incidence of crohn’s disease and ulcerative colitis in the EPIC-Spain cohort

    Nutrients, Vol. 13, Núm. 7

  6. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  7. Relationship between the risk of gastric cancer and adherence to the mediterranean diet according to different estimators. Mcc—spain study

    Cancers, Vol. 13, Núm. 21

  8. The association of nighttime fasting duration and prostate cancer risk: Results from the multicase-control (mcc) study in Spain

    Nutrients, Vol. 13, Núm. 8

  9. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study

    BMC Cancer, Vol. 21, Núm. 1